Mercy Health Joins FDA National EAP for Convalescent Plasma
Mercy Health has joined the Food and Drug Administration’s (FDA) national Expanded Access Program (EAP) for Convalescent Plasma as a treatment protocol for COVID-19.
Learn MoreModern Healthcare Recognizes Bon Secours Mercy Health President and CEO John Starcher as one of the 100 Most Influential People
The complete ranking can be found in this week’s issue of Modern Healthcare magazine.
Learn More